Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)

Borderline Resectable ◽

Clinical Benefits

Comment on “Interpreting Clinical Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer (BRPC)”

Annals of Surgery ◽

10.1097/sla.0000000000003115 ◽

2019 ◽

Vol 270 (2) ◽

pp. e48-e50 ◽

Cited By ~ 1

Author(s):

Zachary R. McCaw ◽

Lu Tian ◽

Dae Hyun Kim ◽

Lee-Jen Wei

Keyword(s):

Pancreatic Cancer ◽

Borderline Resectable ◽

Clinical Benefits

Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2014.09.010 ◽

2014 ◽

Vol 113 (1) ◽

pp. 41-46 ◽

Cited By ~ 33

Author(s):

Jordan Kharofa ◽

Susan Tsai ◽

Tracy Kelly ◽

Clint Wood ◽

Ben George ◽

...

Keyword(s):

Pancreatic Cancer ◽

Borderline Resectable ◽

Preoperative MDCT Assessment of Resectability in Borderline Resectable Pancreatic Cancer: Effect of Neoadjuvant Chemoradiation Therapy

American Journal of Roentgenology ◽

10.2214/ajr.17.18310 ◽

2018 ◽

Vol 210 (5) ◽

pp. 1059-1065 ◽

Cited By ~ 5

Author(s):

Ijin Joo ◽

Jeong Min Lee ◽

Eun Sun Lee ◽

Su Joa Ahn ◽

Dong Ho Lee ◽

...

Keyword(s):

Pancreatic Cancer ◽

Chemoradiation Therapy ◽

Borderline Resectable ◽

Neoadjuvant Chemoradiation Therapy

Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer

Annals of Surgery ◽

10.1097/sla.0000000000002705 ◽

2018 ◽

Vol 268 (2) ◽

pp. 215-222 ◽

Cited By ~ 139

Author(s):

Jin-Young Jang ◽

Youngmin Han ◽

Hongeun Lee ◽

Sun-Whe Kim ◽

Wooil Kwon ◽

...

Keyword(s):

Pancreatic Cancer ◽

Borderline Resectable ◽

Appraisal for neoadjuvant chemoradiation therapy in borderline resectable pancreatic cancer; special reference to isolated venous vascular involvement

Pancreatology ◽

10.1016/j.pan.2013.07.156 ◽

2013 ◽

Vol 13 (4) ◽

pp. S36

Author(s):

Jin Ho Lee ◽

Chang Moo Kang

Keyword(s):

Pancreatic Cancer ◽

Special Reference ◽

Chemoradiation Therapy ◽

Vascular Involvement ◽

Borderline Resectable ◽

Neoadjuvant Chemoradiation Therapy

Neoadjuvant chemoradiation is associated with decreased lymph node ratio in borderline resectable pancreatic cancer: A propensity score matched analysis

Hepatobiliary & Pancreatic Diseases International ◽

10.1016/j.hbpd.2020.08.001 ◽

2020 ◽

Author(s):

June S. Peng ◽

Gareth Morris-Stiff ◽

Noaman S. Ali ◽

Jane Wey ◽

Sricharan Chalikonda ◽

...

Keyword(s):

Pancreatic Cancer ◽

Lymph Node ◽

Propensity Score ◽

Lymph Node Ratio ◽

Borderline Resectable ◽

Node Ratio

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement

Medicine ◽

10.1097/md.0000000000001233 ◽

2015 ◽

Vol 94 (31) ◽

pp. e1233 ◽

Cited By ~ 16

Author(s):

Jin Ho Lee ◽

Chang Moo Kang ◽

Seung Min Bang ◽

Jin Young Choi ◽

Jin Sil Seong ◽

...

Keyword(s):

Pancreatic Cancer ◽

Chemoradiation Therapy ◽

Vascular Involvement ◽

Borderline Resectable ◽

Neoadjuvant Chemoradiation Therapy

Maximizing the Effect of Neoadjuvant Chemoradiation in Patients with Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.1804 ◽

2011 ◽

Vol 81 (2) ◽

pp. S335

Author(s):

D.M. Sopka ◽

Y.S. Chun ◽

S.J. Cohen ◽

F. Zhu ◽

B.N. Milestone ◽

...

Keyword(s):

Pancreatic Cancer ◽

Borderline Resectable ◽

IMRT vs. 3D Conformal Neoadjuvant Chemoradiation for Resectable and Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.760 ◽

2010 ◽

Vol 78 (3) ◽

pp. S320

Author(s):

C. Wood ◽

T. Kelly ◽

D. Prah ◽

P. Ritch ◽

D. Evans ◽

...

Keyword(s):

Pancreatic Cancer ◽

Borderline Resectable ◽

Resection of borderline resectable pancreatic cancer after neoadjuvant chemoradiation does not depend on improved radiographic appearance of tumor–vessel relationships

Journal of Radiation Oncology ◽

10.1007/s13566-013-0115-6 ◽

2013 ◽

Vol 2 (4) ◽

pp. 413-425 ◽

Cited By ~ 43

Author(s):

Avani S. Dholakia ◽

Amy Hacker-Prietz ◽

Aaron T. Wild ◽

Siva P. Raman ◽

Laura D. Wood ◽

...

Keyword(s):

Pancreatic Cancer ◽

Tumor Vessel ◽

Borderline Resectable ◽

Radiographic Appearance ◽